nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—ATP6V1A—hair follicle—skin cancer	0.0514	0.168	CbGeAlD
Etidronic acid—PTPRS—connective tissue—skin cancer	0.0429	0.14	CbGeAlD
Etidronic acid—ATP6V1A—nipple—skin cancer	0.0349	0.114	CbGeAlD
Etidronic acid—PTPRS—female reproductive system—skin cancer	0.0303	0.099	CbGeAlD
Etidronic acid—PTPRS—head—skin cancer	0.0253	0.0827	CbGeAlD
Etidronic acid—ATP6V1A—skin of body—skin cancer	0.0223	0.0731	CbGeAlD
Etidronic acid—ATP6V1A—mammalian vulva—skin cancer	0.0204	0.0667	CbGeAlD
Etidronic acid—ATP6V1A—lymphoid tissue—skin cancer	0.0181	0.0592	CbGeAlD
Etidronic acid—PTPRS—lymph node—skin cancer	0.0177	0.0579	CbGeAlD
Etidronic acid—ATP6V1A—female reproductive system—skin cancer	0.0174	0.0571	CbGeAlD
Etidronic acid—ATP6V1A—head—skin cancer	0.0146	0.0477	CbGeAlD
Etidronic acid—Rash maculo-papular—Vemurafenib—skin cancer	0.0132	0.0196	CcSEcCtD
Etidronic acid—Bone pain—Imiquimod—skin cancer	0.013	0.0192	CcSEcCtD
Etidronic acid—Arthritis—Vemurafenib—skin cancer	0.0109	0.0161	CcSEcCtD
Etidronic acid—Risedronate—PTGS2—skin cancer	0.0105	0.529	CrCbGaD
Etidronic acid—Alopecia—Vismodegib—skin cancer	0.0105	0.0155	CcSEcCtD
Etidronic acid—ATP6V1A—lymph node—skin cancer	0.0102	0.0334	CbGeAlD
Etidronic acid—Muscle spasms—Vismodegib—skin cancer	0.0099	0.0147	CcSEcCtD
Etidronic acid—Clodronate—PTGS2—skin cancer	0.00936	0.471	CrCbGaD
Etidronic acid—Arthritis—Imiquimod—skin cancer	0.00927	0.0137	CcSEcCtD
Etidronic acid—Arthralgia—Vismodegib—skin cancer	0.00877	0.013	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00807	0.012	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Vemurafenib—skin cancer	0.00798	0.0118	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00766	0.0113	CcSEcCtD
Etidronic acid—Oesophagitis—Dactinomycin—skin cancer	0.00751	0.0111	CcSEcCtD
Etidronic acid—Dyspepsia—Vismodegib—skin cancer	0.0074	0.011	CcSEcCtD
Etidronic acid—Pancytopenia—Imiquimod—skin cancer	0.00739	0.011	CcSEcCtD
Etidronic acid—Constipation—Vismodegib—skin cancer	0.00719	0.0106	CcSEcCtD
Etidronic acid—Erythema multiforme—Vemurafenib—skin cancer	0.00691	0.0102	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00688	0.0102	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Vismodegib—skin cancer	0.00687	0.0102	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Imiquimod—skin cancer	0.0068	0.0101	CcSEcCtD
Etidronic acid—Abdominal pain—Vismodegib—skin cancer	0.00664	0.00985	CcSEcCtD
Etidronic acid—Arthritis—Bleomycin—skin cancer	0.00658	0.00976	CcSEcCtD
Etidronic acid—Alopecia—Vemurafenib—skin cancer	0.00646	0.00957	CcSEcCtD
Etidronic acid—Erythema—Vemurafenib—skin cancer	0.00636	0.00943	CcSEcCtD
Etidronic acid—Oesophagitis—Fluorouracil—skin cancer	0.00626	0.00928	CcSEcCtD
Etidronic acid—Rash maculo-papular—Fluorouracil—skin cancer	0.00623	0.00923	CcSEcCtD
Etidronic acid—Pruritus—Vismodegib—skin cancer	0.00594	0.00881	CcSEcCtD
Etidronic acid—Erythema multiforme—Imiquimod—skin cancer	0.00589	0.00873	CcSEcCtD
Etidronic acid—Diarrhoea—Vismodegib—skin cancer	0.00575	0.00852	CcSEcCtD
Etidronic acid—Amnesia—Temozolomide—skin cancer	0.00575	0.00852	CcSEcCtD
Etidronic acid—Alopecia—Imiquimod—skin cancer	0.00551	0.00816	CcSEcCtD
Etidronic acid—Erythema—Imiquimod—skin cancer	0.00542	0.00804	CcSEcCtD
Etidronic acid—Arthralgia—Vemurafenib—skin cancer	0.00542	0.00803	CcSEcCtD
Etidronic acid—Vomiting—Vismodegib—skin cancer	0.00534	0.00792	CcSEcCtD
Etidronic acid—Rash—Vismodegib—skin cancer	0.0053	0.00785	CcSEcCtD
Etidronic acid—Amnesia—Fluorouracil—skin cancer	0.00529	0.00785	CcSEcCtD
Etidronic acid—Dermatitis—Vismodegib—skin cancer	0.00529	0.00785	CcSEcCtD
Etidronic acid—Pancytopenia—Bleomycin—skin cancer	0.00525	0.00778	CcSEcCtD
Etidronic acid—Bone pain—Docetaxel—skin cancer	0.00516	0.00765	CcSEcCtD
Etidronic acid—Infection—Vemurafenib—skin cancer	0.00516	0.00764	CcSEcCtD
Etidronic acid—Nausea—Vismodegib—skin cancer	0.00499	0.0074	CcSEcCtD
Etidronic acid—Osteoarthritis—Fluorouracil—skin cancer	0.00497	0.00737	CcSEcCtD
Etidronic acid—Angioedema—Imiquimod—skin cancer	0.00496	0.00735	CcSEcCtD
Etidronic acid—Pancytopenia—Dactinomycin—skin cancer	0.0049	0.00726	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00473	0.00701	CcSEcCtD
Etidronic acid—Arthralgia—Imiquimod—skin cancer	0.00462	0.00684	CcSEcCtD
Etidronic acid—Discomfort—Imiquimod—skin cancer	0.00456	0.00676	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00456	0.00676	CcSEcCtD
Etidronic acid—Oesophagitis—Docetaxel—skin cancer	0.00452	0.0067	CcSEcCtD
Etidronic acid—Constipation—Vemurafenib—skin cancer	0.00444	0.00658	CcSEcCtD
Etidronic acid—Pancytopenia—Temozolomide—skin cancer	0.00443	0.00657	CcSEcCtD
Etidronic acid—Infection—Imiquimod—skin cancer	0.0044	0.00652	CcSEcCtD
Etidronic acid—Agranulocytosis—Dactinomycin—skin cancer	0.00429	0.00636	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00412	0.00611	CcSEcCtD
Etidronic acid—Pancytopenia—Fluorouracil—skin cancer	0.00408	0.00605	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Temozolomide—skin cancer	0.00408	0.00604	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00403	0.00598	CcSEcCtD
Etidronic acid—Paraesthesia—Imiquimod—skin cancer	0.00398	0.00589	CcSEcCtD
Etidronic acid—Alopecia—Bleomycin—skin cancer	0.00391	0.0058	CcSEcCtD
Etidronic acid—Erythema multiforme—Dactinomycin—skin cancer	0.0039	0.00579	CcSEcCtD
Etidronic acid—Dyspepsia—Imiquimod—skin cancer	0.0039	0.00578	CcSEcCtD
Etidronic acid—Erythema—Bleomycin—skin cancer	0.00385	0.00571	CcSEcCtD
Etidronic acid—Hypersensitivity—Vemurafenib—skin cancer	0.00382	0.00567	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Fluorouracil—skin cancer	0.00376	0.00557	CcSEcCtD
Etidronic acid—Hallucination—Temozolomide—skin cancer	0.00372	0.00551	CcSEcCtD
Etidronic acid—Pruritus—Vemurafenib—skin cancer	0.00367	0.00544	CcSEcCtD
Etidronic acid—Alopecia—Dactinomycin—skin cancer	0.00365	0.00541	CcSEcCtD
Etidronic acid—Feeling abnormal—Imiquimod—skin cancer	0.00365	0.00541	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Imiquimod—skin cancer	0.00362	0.00537	CcSEcCtD
Etidronic acid—Erythema—Dactinomycin—skin cancer	0.00359	0.00533	CcSEcCtD
Etidronic acid—Agranulocytosis—Fluorouracil—skin cancer	0.00358	0.0053	CcSEcCtD
Etidronic acid—Anaemia—Bleomycin—skin cancer	0.00356	0.00528	CcSEcCtD
Etidronic acid—Diarrhoea—Vemurafenib—skin cancer	0.00355	0.00526	CcSEcCtD
Etidronic acid—Erythema multiforme—Temozolomide—skin cancer	0.00353	0.00523	CcSEcCtD
Etidronic acid—Urticaria—Imiquimod—skin cancer	0.00352	0.00521	CcSEcCtD
Etidronic acid—Abdominal pain—Imiquimod—skin cancer	0.0035	0.00519	CcSEcCtD
Etidronic acid—Leukopenia—Bleomycin—skin cancer	0.00345	0.00511	CcSEcCtD
Etidronic acid—Anaemia—Dactinomycin—skin cancer	0.00332	0.00492	CcSEcCtD
Etidronic acid—Vomiting—Vemurafenib—skin cancer	0.0033	0.00489	CcSEcCtD
Etidronic acid—Alopecia—Temozolomide—skin cancer	0.0033	0.00489	CcSEcCtD
Etidronic acid—Rash—Vemurafenib—skin cancer	0.00327	0.00485	CcSEcCtD
Etidronic acid—Dermatitis—Vemurafenib—skin cancer	0.00327	0.00485	CcSEcCtD
Etidronic acid—Hypersensitivity—Imiquimod—skin cancer	0.00326	0.00483	CcSEcCtD
Etidronic acid—Headache—Vemurafenib—skin cancer	0.00325	0.00482	CcSEcCtD
Etidronic acid—Erythema—Temozolomide—skin cancer	0.00325	0.00482	CcSEcCtD
Etidronic acid—Discomfort—Bleomycin—skin cancer	0.00324	0.0048	CcSEcCtD
Etidronic acid—Leukopenia—Dactinomycin—skin cancer	0.00322	0.00477	CcSEcCtD
Etidronic acid—Confusional state—Bleomycin—skin cancer	0.00317	0.0047	CcSEcCtD
Etidronic acid—Pruritus—Imiquimod—skin cancer	0.00313	0.00464	CcSEcCtD
Etidronic acid—Infection—Bleomycin—skin cancer	0.00312	0.00463	CcSEcCtD
Etidronic acid—Nausea—Vemurafenib—skin cancer	0.00308	0.00457	CcSEcCtD
Etidronic acid—Alopecia—Fluorouracil—skin cancer	0.00304	0.00451	CcSEcCtD
Etidronic acid—Diarrhoea—Imiquimod—skin cancer	0.00303	0.00449	CcSEcCtD
Etidronic acid—Discomfort—Dactinomycin—skin cancer	0.00302	0.00448	CcSEcCtD
Etidronic acid—Anaemia—Temozolomide—skin cancer	0.003	0.00445	CcSEcCtD
Etidronic acid—Erythema—Fluorouracil—skin cancer	0.003	0.00444	CcSEcCtD
Etidronic acid—Angioedema—Temozolomide—skin cancer	0.00297	0.0044	CcSEcCtD
Etidronic acid—Pancytopenia—Docetaxel—skin cancer	0.00295	0.00437	CcSEcCtD
Etidronic acid—Infection—Dactinomycin—skin cancer	0.00291	0.00432	CcSEcCtD
Etidronic acid—Leukopenia—Temozolomide—skin cancer	0.00291	0.00431	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00287	0.00425	CcSEcCtD
Etidronic acid—Paraesthesia—Bleomycin—skin cancer	0.00282	0.00419	CcSEcCtD
Etidronic acid—Vomiting—Imiquimod—skin cancer	0.00281	0.00417	CcSEcCtD
Etidronic acid—Rash—Imiquimod—skin cancer	0.00279	0.00414	CcSEcCtD
Etidronic acid—Dermatitis—Imiquimod—skin cancer	0.00279	0.00413	CcSEcCtD
Etidronic acid—Headache—Imiquimod—skin cancer	0.00277	0.00411	CcSEcCtD
Etidronic acid—Anaemia—Fluorouracil—skin cancer	0.00277	0.0041	CcSEcCtD
Etidronic acid—Arthralgia—Temozolomide—skin cancer	0.00277	0.0041	CcSEcCtD
Etidronic acid—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00274	0.00406	CcSEcCtD
Etidronic acid—Discomfort—Temozolomide—skin cancer	0.00273	0.00405	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Docetaxel—skin cancer	0.00271	0.00402	CcSEcCtD
Etidronic acid—Leukopenia—Fluorouracil—skin cancer	0.00268	0.00397	CcSEcCtD
Etidronic acid—Confusional state—Temozolomide—skin cancer	0.00268	0.00396	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00267	0.00396	CcSEcCtD
Etidronic acid—Infection—Temozolomide—skin cancer	0.00264	0.00391	CcSEcCtD
Etidronic acid—Nausea—Imiquimod—skin cancer	0.00263	0.0039	CcSEcCtD
Etidronic acid—Feeling abnormal—Bleomycin—skin cancer	0.00259	0.00384	CcSEcCtD
Etidronic acid—Agranulocytosis—Docetaxel—skin cancer	0.00258	0.00383	CcSEcCtD
Etidronic acid—Discomfort—Fluorouracil—skin cancer	0.00252	0.00373	CcSEcCtD
Etidronic acid—Urticaria—Bleomycin—skin cancer	0.0025	0.0037	CcSEcCtD
Etidronic acid—Confusional state—Fluorouracil—skin cancer	0.00246	0.00365	CcSEcCtD
Etidronic acid—Infection—Fluorouracil—skin cancer	0.00243	0.0036	CcSEcCtD
Etidronic acid—Feeling abnormal—Dactinomycin—skin cancer	0.00242	0.00358	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00242	0.00358	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Dactinomycin—skin cancer	0.0024	0.00356	CcSEcCtD
Etidronic acid—Paraesthesia—Temozolomide—skin cancer	0.00238	0.00353	CcSEcCtD
Etidronic acid—Erythema multiforme—Docetaxel—skin cancer	0.00235	0.00348	CcSEcCtD
Etidronic acid—Dyspepsia—Temozolomide—skin cancer	0.00234	0.00346	CcSEcCtD
Etidronic acid—Abdominal pain—Dactinomycin—skin cancer	0.00232	0.00344	CcSEcCtD
Etidronic acid—Hypersensitivity—Bleomycin—skin cancer	0.00232	0.00343	CcSEcCtD
Etidronic acid—Constipation—Temozolomide—skin cancer	0.00227	0.00336	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00223	0.0033	CcSEcCtD
Etidronic acid—Pruritus—Bleomycin—skin cancer	0.00223	0.0033	CcSEcCtD
Etidronic acid—Paraesthesia—Fluorouracil—skin cancer	0.0022	0.00325	CcSEcCtD
Etidronic acid—Alopecia—Docetaxel—skin cancer	0.00219	0.00325	CcSEcCtD
Etidronic acid—Feeling abnormal—Temozolomide—skin cancer	0.00219	0.00324	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Temozolomide—skin cancer	0.00217	0.00322	CcSEcCtD
Etidronic acid—Erythema—Docetaxel—skin cancer	0.00216	0.0032	CcSEcCtD
Etidronic acid—Hypersensitivity—Dactinomycin—skin cancer	0.00216	0.0032	CcSEcCtD
Etidronic acid—Dyspepsia—Fluorouracil—skin cancer	0.00215	0.00319	CcSEcCtD
Etidronic acid—Urticaria—Temozolomide—skin cancer	0.00211	0.00312	CcSEcCtD
Etidronic acid—Abdominal pain—Temozolomide—skin cancer	0.0021	0.00311	CcSEcCtD
Etidronic acid—Muscle spasms—Docetaxel—skin cancer	0.00208	0.00308	CcSEcCtD
Etidronic acid—Feeling abnormal—Fluorouracil—skin cancer	0.00201	0.00299	CcSEcCtD
Etidronic acid—Diarrhoea—Dactinomycin—skin cancer	0.00201	0.00297	CcSEcCtD
Etidronic acid—Vomiting—Bleomycin—skin cancer	0.002	0.00296	CcSEcCtD
Etidronic acid—Anaemia—Docetaxel—skin cancer	0.002	0.00296	CcSEcCtD
Etidronic acid—Rash—Bleomycin—skin cancer	0.00198	0.00294	CcSEcCtD
Etidronic acid—Dermatitis—Bleomycin—skin cancer	0.00198	0.00294	CcSEcCtD
Etidronic acid—Hypersensitivity—Temozolomide—skin cancer	0.00195	0.0029	CcSEcCtD
Etidronic acid—Urticaria—Fluorouracil—skin cancer	0.00194	0.00288	CcSEcCtD
Etidronic acid—Leukopenia—Docetaxel—skin cancer	0.00194	0.00287	CcSEcCtD
Etidronic acid—Pruritus—Temozolomide—skin cancer	0.00188	0.00278	CcSEcCtD
Etidronic acid—Nausea—Bleomycin—skin cancer	0.00187	0.00277	CcSEcCtD
Etidronic acid—Vomiting—Dactinomycin—skin cancer	0.00187	0.00276	CcSEcCtD
Etidronic acid—Rash—Dactinomycin—skin cancer	0.00185	0.00274	CcSEcCtD
Etidronic acid—Arthralgia—Docetaxel—skin cancer	0.00184	0.00273	CcSEcCtD
Etidronic acid—Diarrhoea—Temozolomide—skin cancer	0.00182	0.00269	CcSEcCtD
Etidronic acid—Hypersensitivity—Fluorouracil—skin cancer	0.0018	0.00267	CcSEcCtD
Etidronic acid—Confusional state—Docetaxel—skin cancer	0.00178	0.00264	CcSEcCtD
Etidronic acid—Infection—Docetaxel—skin cancer	0.00175	0.0026	CcSEcCtD
Etidronic acid—Nausea—Dactinomycin—skin cancer	0.00174	0.00258	CcSEcCtD
Etidronic acid—Pruritus—Fluorouracil—skin cancer	0.00173	0.00256	CcSEcCtD
Etidronic acid—Vomiting—Temozolomide—skin cancer	0.00169	0.0025	CcSEcCtD
Etidronic acid—Rash—Temozolomide—skin cancer	0.00167	0.00248	CcSEcCtD
Etidronic acid—Diarrhoea—Fluorouracil—skin cancer	0.00167	0.00248	CcSEcCtD
Etidronic acid—Dermatitis—Temozolomide—skin cancer	0.00167	0.00248	CcSEcCtD
Etidronic acid—Headache—Temozolomide—skin cancer	0.00166	0.00246	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00161	0.00238	CcSEcCtD
Etidronic acid—Paraesthesia—Docetaxel—skin cancer	0.00158	0.00235	CcSEcCtD
Etidronic acid—Nausea—Temozolomide—skin cancer	0.00158	0.00234	CcSEcCtD
Etidronic acid—Vomiting—Fluorouracil—skin cancer	0.00155	0.0023	CcSEcCtD
Etidronic acid—Dyspepsia—Docetaxel—skin cancer	0.00155	0.0023	CcSEcCtD
Etidronic acid—Rash—Fluorouracil—skin cancer	0.00154	0.00228	CcSEcCtD
Etidronic acid—Dermatitis—Fluorouracil—skin cancer	0.00154	0.00228	CcSEcCtD
Etidronic acid—Headache—Fluorouracil—skin cancer	0.00153	0.00227	CcSEcCtD
Etidronic acid—Constipation—Docetaxel—skin cancer	0.00151	0.00224	CcSEcCtD
Etidronic acid—Feeling abnormal—Docetaxel—skin cancer	0.00145	0.00215	CcSEcCtD
Etidronic acid—Nausea—Fluorouracil—skin cancer	0.00145	0.00215	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Docetaxel—skin cancer	0.00144	0.00214	CcSEcCtD
Etidronic acid—Abdominal pain—Docetaxel—skin cancer	0.00139	0.00207	CcSEcCtD
Etidronic acid—Hypersensitivity—Docetaxel—skin cancer	0.0013	0.00193	CcSEcCtD
Etidronic acid—Pruritus—Docetaxel—skin cancer	0.00125	0.00185	CcSEcCtD
Etidronic acid—Diarrhoea—Docetaxel—skin cancer	0.00121	0.00179	CcSEcCtD
Etidronic acid—Vomiting—Docetaxel—skin cancer	0.00112	0.00166	CcSEcCtD
Etidronic acid—Rash—Docetaxel—skin cancer	0.00111	0.00165	CcSEcCtD
Etidronic acid—Dermatitis—Docetaxel—skin cancer	0.00111	0.00165	CcSEcCtD
Etidronic acid—Headache—Docetaxel—skin cancer	0.00111	0.00164	CcSEcCtD
Etidronic acid—Nausea—Docetaxel—skin cancer	0.00105	0.00155	CcSEcCtD
